Amritsar: Narcotics Control Bureau expands probe

LocalPolitics
1 Jul 2026 • 11:26 AM MYT
Tribune
Tribune

Breaking news, top headlines, in-depth analysis, & exclusive stories

Image from: Amritsar: Narcotics Control  Bureau expands probe
Scientific evidence has consistently shown that higher doses of nimesulide significantly increase the risk of hepatotoxicity, sometimes with fatal consequences.

The Narcotics Control Bureau (NCB) has issued a fresh notice to Dr Inderpal Singh, owner of a private hospital in Haripura, directing him to appear before the agency on Monday in connection with its investigation into the alleged illegal trade in restricted medicines.

NCB officials said Dr Inderpal has been asked to produce complete records related to the purchase and sale of restricted medicines. He had earlier appeared before the central agency, but failed to submit the entire documentation sought during questioning, an official said on condition of anonymity.

The probe stems from an NCB raid conducted in May at Baba Deep Singh Hospital in a village near the Attari border.

Acting on intelligence inputs, the agency had alleged that the hospital owner, Dr Charanpreet Singh, was procuring restricted medicines in quantities exceeding the permissible limit. During the search, officials reportedly recovered between 800 and 1,000 tablets in excess of the authorised stock, following which Dr Charanpreet Singh was arrested.

During the course of the investigation, the name of a private hospital in Haripura owned by Dr Inderpal surfaced, prompting the NCB to widen its probe, sources said. Officials are now examining records related to the procurement and distribution of restricted medicines.

Sources further indicated that the names of certain stockists based in Moga and Ludhiana have also surfaced. Notices are likely to be issued to them. No formal charges have been filed against Dr Inderpal Singh so far and the investigation is continuing.

Newswav Malaysia Best News App

Newswav is an online content aggregator and obtains its content from different online sources. The content in the app do not belong to Newswav nor do they reflect the opinions of Newswav and its staff. Your use of this app indicates your understanding and acceptance of this information.

Newswav Sdn. Bhd. (201701008480 (1222645-M)) 2026 All Rights Reserved